{"id":"W2988092601","doi":"10.1001/jamadermatol.2019.3336","title":"Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis","year":2019,"lang":"en","type":"article","venue":"JAMA Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":509,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Probity Medical Research; SKiN Health","funders":"Sanofi Genzyme; LEO Pharma; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Dupilumab; Eczema Area and Severity Index; Atopic dermatitis; Randomized controlled trial; Dermatology Life Quality Index; SCORAD; Placebo; Internal medicine; Population; Quality of life (healthcare); Clinical endpoint; Pediatrics; Dermatology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005050114,0.0001766177,0.0007779573,0.0002015172,0.00003160337,0.000009504839,0.00008878336,0.0001894539,0.0000611467],"category_scores_gemma":[0.00008235284,0.0001440065,0.00004270887,0.0001812249,0.00009341128,0.0001011574,0.00005801639,0.0001981087,0.00007898429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002505869,"about_ca_system_score_gemma":0.000109676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002677649,"about_ca_topic_score_gemma":0.00006600513,"domain_scores_codex":[0.9987507,0.0001303938,0.0004028159,0.0002782658,0.0001342354,0.0003036022],"domain_scores_gemma":[0.9992836,0.00008648451,0.00009472482,0.000297726,0.00007768446,0.0001598411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004642125,0.0002352355,0.9910677,0.00062398,0.00007945327,0.000644771,0.0003262235,0.00007727715,0.00007529683,0.0003121219,0.0008882327,0.001027596],"study_design_scores_gemma":[0.02908248,0.0001117088,0.963983,0.0008223468,0.00006674568,0.003733413,0.0000997227,0.0007120642,0.0005112378,0.0001171608,0.0005968531,0.0001632563],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920872,0.0005766826,0.00007776263,0.004341658,0.00006955727,0.0009063764,0.000007233078,0.00003182742,0.001901632],"genre_scores_gemma":[0.9964086,0.00003790802,0.0001709495,0.00322389,0.00001056707,0.0000253166,0.00001092251,0.0000167112,0.00009517402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02708467,"threshold_uncertainty_score":0.5872415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005197194933641165,"score_gpt":0.231256539369391,"score_spread":0.2260593444357498,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}